BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7512554)

  • 1. Processing and surface presentation of the Mycoplasma hyorhinis variant lipoprotein VlpC.
    Cleavinger CM; Kim MF; Wise KS
    J Bacteriol; 1994 Apr; 176(8):2463-7. PubMed ID: 7512554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.
    Rosengarten R; Wise KS
    J Bacteriol; 1991 Aug; 173(15):4782-93. PubMed ID: 1856172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased structural and combinatorial diversity in an extended family of genes encoding Vlp surface proteins of Mycoplasma hyorhinis.
    Yogev D; Watson-McKown R; Rosengarten R; Im J; Wise KS
    J Bacteriol; 1995 Oct; 177(19):5636-43. PubMed ID: 7559353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic topology of the P29 surface lipoprotein of Mycoplasma fermentans: differential display of epitopes results in high-frequency phase variation.
    Theiss P; Karpas A; Wise KS
    Infect Immun; 1996 May; 64(5):1800-9. PubMed ID: 8613394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5' regulatory sequences.
    Yogev D; Rosengarten R; Watson-McKown R; Wise KS
    EMBO J; 1991 Dec; 10(13):4069-79. PubMed ID: 1721868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence and TnphoA analysis of a Mycoplasma hyorhinis protein with membrane export function.
    Yogev D; Watson-McKown R; McIntosh MA; Wise KS
    J Bacteriol; 1991 Mar; 173(6):2035-44. PubMed ID: 1848219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolipoprotein modification and processing in Escherichia coli. A unique secondary structure in prolipoprotein signal sequence for the recognition by glyceryl transferase.
    Giam CZ; Chai T; Hayashi S; Wu HC
    Eur J Biochem; 1984 Jun; 141(2):331-7. PubMed ID: 6428886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mycoplasma membrane proteins by systematic Tn phoA mutagenesis of a recombinant library.
    Cleavinger CM; Kim MF; Im JH; Wise KS
    Mol Microbiol; 1995 Oct; 18(2):283-93. PubMed ID: 8709847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Mycoplasma arthritidis membrane lipoprotein MAA1.
    Washburn LR; Miller EJ; Weaver KE
    Infect Immun; 2000 Feb; 68(2):437-42. PubMed ID: 10639401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoproteins in bacteria.
    Hayashi S; Wu HC
    J Bioenerg Biomembr; 1990 Jun; 22(3):451-71. PubMed ID: 2202727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.
    Citti C; Kim MF; Wise KS
    Infect Immun; 1997 May; 65(5):1773-85. PubMed ID: 9125561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lipoprotein signal peptide plus a cysteine residue at the amino-terminal end of the periplasmic protein beta-lactamase is sufficient for its lipid modification, processing and membrane localization in Escherichia coli.
    Oudega B; Clark D; Stegehuis F; Majoor MJ; Luirink J
    FEMS Microbiol Lett; 1993 Apr; 108(3):353-9. PubMed ID: 8514122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoplasma hyorhinis vlp gene transcription: critical role in phase variation and expression of surface lipoproteins.
    Citti C; Wise KS
    Mol Microbiol; 1995 Nov; 18(4):649-60. PubMed ID: 8817488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and expression of a surface lipoprotein of Mycoplasma capricolum as a potential antigen for serological diagnosis.
    Robino P; Alberti A; Chessa B; Pittau M; Profiti M; Rosati S
    Vet Res Commun; 2007 Aug; 31 Suppl 1():257-60. PubMed ID: 17682889
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
    Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
    Infect Immun; 1998 Oct; 66(10):4804-10. PubMed ID: 9746582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-modified surface protein antigens expressing size variation within the species Mycoplasma hyorhinis.
    Boyer MJ; Wise KS
    Infect Immun; 1989 Jan; 57(1):245-54. PubMed ID: 2462538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the "blue halo" assay in the identification of genes encoding exported proteins with cleavable signal peptides: cloning of a Borrelia burgdorferi plasmid gene with a signal peptide.
    Giladi M; Champion CI; Haake DA; Blanco DR; Miller JF; Miller JN; Lovett MA
    J Bacteriol; 1993 Jul; 175(13):4129-36. PubMed ID: 8320228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli expression and processing of human interleukin-1 beta fused to signal peptides.
    Curry KA; Yem AW; Deibel MR; Hatzenbuhler NT; Hoogerheide JG; Tomich CS
    DNA Cell Biol; 1990 Apr; 9(3):167-75. PubMed ID: 2187479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the role in adherence of Mycoplasma hyorhinis variable lipoproteins containing different repeat unit copy numbers.
    Xiong Q; Zhang B; Wang J; Ni B; Ji Y; Wei Y; Xiao S; Feng Z; Liu M; Shao G
    Vet Microbiol; 2016 Dec; 197():39-46. PubMed ID: 27938681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fusion plasmid for the synthesis of lipopeptide-antigen chimeras in Escherichia coli.
    Rioux CR; Bergeron H; Lin L; Grothe S; O'Connor-McCourt M; Lau PC
    Gene; 1992 Jul; 116(1):13-20. PubMed ID: 1628839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.